BidaskClub lowered shares of Natus Medical Incorporated (NASDAQ:BABY) from a sell rating to a strong sell rating in a report issued on Thursday morning.
BABY has been the topic of several other reports. Zacks Investment Research raised shares of Natus Medical from a sell rating to a hold rating in a research report on Tuesday, June 27th. Benchmark Co. reissued a buy rating and set a $48.00 price objective (down from $55.00) on shares of Natus Medical in a research report on Monday, May 1st. Finally, TheStreet downgraded shares of Natus Medical from a b rating to a c+ rating in a research report on Thursday, April 27th. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company. The stock currently has a consensus rating of Hold and an average target price of $45.00.
Shares of Natus Medical (NASDAQ:BABY) traded down 0.46% during midday trading on Thursday, reaching $32.65. 88,127 shares of the company’s stock traded hands. Natus Medical has a 12 month low of $31.65 and a 12 month high of $44.39. The stock has a market cap of $1.06 billion, a P/E ratio of 56.59 and a beta of 0.93. The stock has a 50 day moving average of $35.55 and a 200-day moving average of $36.39.
Natus Medical (NASDAQ:BABY) last announced its quarterly earnings data on Wednesday, July 26th. The medical equipment provider reported $0.34 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.33 by $0.01. Natus Medical had a net margin of 4.20% and a return on equity of 12.09%. The company had revenue of $122.20 million for the quarter, compared to the consensus estimate of $121.99 million. During the same period in the prior year, the firm posted $0.39 EPS. Natus Medical’s revenue for the quarter was up 27.3% on a year-over-year basis. On average, equities research analysts forecast that Natus Medical will post $1.70 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “Natus Medical Incorporated (BABY) Lowered to Strong Sell at BidaskClub” was published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright law. The correct version of this report can be accessed at https://stocknewstimes.com/2017/08/25/natus-medical-incorporated-baby-lowered-to-strong-sell-at-bidaskclub.html.
In related news, insider James B. Hawkins bought 6,000 shares of the stock in a transaction on Wednesday, May 31st. The shares were acquired at an average price of $33.81 per share, for a total transaction of $202,860.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director William M. Moore sold 3,000 shares of the company’s stock in a transaction dated Monday, August 14th. The shares were sold at an average price of $34.10, for a total transaction of $102,300.00. Following the transaction, the director now owns 30,410 shares in the company, valued at approximately $1,036,981. The disclosure for this sale can be found here. Corporate insiders own 5.50% of the company’s stock.
A number of institutional investors have recently bought and sold shares of BABY. Ameritas Investment Partners Inc. bought a new position in Natus Medical during the first quarter valued at about $110,000. Riverhead Capital Management LLC boosted its position in Natus Medical by 90.9% in the second quarter. Riverhead Capital Management LLC now owns 2,864 shares of the medical equipment provider’s stock valued at $107,000 after buying an additional 1,364 shares in the last quarter. Sei Investments Co. boosted its position in Natus Medical by 29.7% in the second quarter. Sei Investments Co. now owns 3,182 shares of the medical equipment provider’s stock valued at $119,000 after buying an additional 728 shares in the last quarter. Victory Capital Management Inc. boosted its position in Natus Medical by 94.0% in the first quarter. Victory Capital Management Inc. now owns 3,184 shares of the medical equipment provider’s stock valued at $125,000 after buying an additional 1,543 shares in the last quarter. Finally, State of Alaska Department of Revenue boosted its position in Natus Medical by 1.7% in the first quarter. State of Alaska Department of Revenue now owns 3,630 shares of the medical equipment provider’s stock valued at $142,000 after buying an additional 60 shares in the last quarter. Institutional investors and hedge funds own 95.66% of the company’s stock.
Natus Medical Company Profile
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Receive News & Ratings for Natus Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.
